We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+13.95%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.5B
AUM Growth
+$1.41B
(+16%)
Cap. Flow
+$347M
Cap. Flow
% of AUM
3.32%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
2,407
New
262
Increased
1,175
Reduced
775
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$34.3M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$28.5M |
| 3 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$24.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$21.4M |
| 5 |
Vanguard Total Bond Market
BND
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$97.5M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$58M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$32.9M |
| 4 |
First Trust Dorsey Wright Focus 5 ETF
FV
|
+$23.2M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.32% |
| 2 | Financials | 4.92% |
| 3 | Healthcare | 4.22% |
| 4 | Consumer Discretionary | 3.74% |
| 5 | Industrials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $2.52M | 0.02% |
+83,286
| New | +$2.48M |
|
|
VBIV
627
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $2.51M | 0.02% |
44,821
-16
| -0% | -$865 |
|
628
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$6.98B
| $2.5M | 0.02% |
76,447
+5,694
| +8% | +$182K |
|
629
Morgan Stanley
MS
$344B
| $2.5M | 0.02% |
59,267
-9,020
| -13% | -$380K |
|
630
Cigna
CI
$73.3B
| $2.5M | 0.02% |
15,526
-334
| -2% | -$61K |
|
631
iShares Morningstar Small-Cap Value ETF
ISCV
$710M
| $2.5M | 0.02% |
54,315
+774
| +1% | +$35.6K |
|
632
Rollins
ROL
$17.5B
| $2.48M | 0.02% |
89,198
+7,833
| +10% | +$204K |
|
633
Cencora
COR
$59.2B
| $2.47M | 0.02% |
31,116
+304
| +1% | +$24.4K |
|
634
WisdomTree Japan Hedged Equity Fund
DXJ
$7.56B
| $2.47M | 0.02% |
48,890
-15,612
| -24% | -$778K |
|
|
BSJL
635
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
| $2.47M | 0.02% |
100,039
+5,476
| +6% | +$134K |
|
636
CapForce IBD 50 ETF
FFTY
$80.5M
| $2.46M | 0.02% |
73,327
+10,755
| +17% | +$338K |
|
637
WisdomTree US LargeCap Fund
EPS
$1.66B
| $2.46M | 0.02% |
77,220
+6,588
| +9% | +$203K |
|
638
Zoetis
ZTS
$31B
| $2.46M | 0.02% |
24,391
+2,343
| +11% | +$213K |
|
639
T. Rowe Price
TROW
$23.8B
| $2.45M | 0.02% |
24,506
-1,078
| -4% | -$104K |
|
640
Fidelity National Information Services
FIS
$22.6B
| $2.45M | 0.02% |
21,669
+6,197
| +40% | +$661K |
|
641
JD.com
JD
$39.6B
| $2.45M | 0.02% |
81,230
+7,976
| +11% | +$203K |
|
642
SLB Ltd
SLB
$77.2B
| $2.44M | 0.02% |
56,106
+364
| +0.7% | +$15.7K |
|
|
CXP
643
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2.43M | 0.02% |
108,026
-4,895
| -4% | -$106K |
|
|
VMW
644
DELISTED
VMware, Inc
VMW
| $2.43M | 0.02% |
13,444
+6,361
| +90% | +$1.04M |
|
645
Freeport-McMoran
FCX
$93.7B
| $2.42M | 0.02% |
188,107
+5,769
| +3% | +$69.8K |
|
646
Public Service Enterprise Group
PEG
$37.8B
| $2.41M | 0.02% |
40,567
-1,383
| -3% | -$77.3K |
|
|
MPT
647
Medical Properties Trust
MPT
$2.48B
| $2.39M | 0.02% |
129,289
+17,343
| +15% | +$309K |
|
648
Royal Bank of Canada
RY
$298B
| $2.38M | 0.02% |
31,522
+65
| +0.2% | +$4.92K |
|
649
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $2.38M | 0.02% |
79,620
+17,198
| +28% | +$504K |
|
650
Unilever
UL
$135B
| $2.37M | 0.02% |
36,474
-668
| -2% | -$40.7K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Cambridge Investment Research Advisors held 2,407 positions worth $10.5B, up 16% from $9.04B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors deployed $347M of net new capital in Q1 2019, opening 262 new positions and adding to 1,175 existing holdings. Its largest new stake was Invesco S&P 500 High Beta ETF: 149,602 shares worth $6.22M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 5.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was TotalEnergies, an estimated $97.5M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2019 buy was Invesco S&P 500 High Beta ETF: 149,602 shares worth $6.22M.
- Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q1 2019, an estimated $34.3M increase.
- Cambridge Investment Research Advisors's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $97.5M.
- Cambridge Investment Research Advisors fully exited ProShares Short S&P500 in Q1 2019, selling an estimated $7.97M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $10.5B portfolio in Q1 2019.
- Cambridge Investment Research Advisors opened 262 new positions and closed 133 in Q1 2019.
- Cambridge Investment Research Advisors's portfolio value rose 16% quarter-over-quarter to $10.5B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.